Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / SCYX - Scynexis: No Compelling Reason To Invest

SCYX - Scynexis: No Compelling Reason To Invest

SCYNEXIS Inc.

Summary

  • Scynexis launched a product for VVC where there is no significant commercial demand.
  • An additional indication in preventing VVC is not likely to significantly increase sales.
  • Commercial sales have been extraordinarily low and the company is responding by stopping commercial promotions.
  • Invasive fungal infections are indications where premium pricing is likely but the profile of ibrexafungerp in these indications is unclear. Data is expected in 2024 and 2025.
  • The current cash balance is approximately $100 m but most of this will be burned to sustain the company into 2024.

For further details see:

Scynexis: No Compelling Reason To Invest
Stock Information
Company Name: SCYNEXIS Inc.
Stock Symbol: SCYX
Market: NASDAQ
Website: scynexis.com
Menu
SCYX SCYX Quote SCYX Short SCYX News SCYX Articles SCYX Message Board
Get SCYX Alerts

News, Short Squeeze, Breakout and More Instantly...